Validation of a new panel of automated chemiluminescence assays for anticardiolipin antibodies in the screening for antiphospholipid syndrome

Clinical Laboratory

Volumn 62, Issue 7, 2016, Pages 1309-1315

  Janek, D ^a,b   Slavik, Ludek ^a   Ulehlova, J ^a   Krcova, V ^a   Hlusi, A ^a   Prochazkova, J ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b Hospital Karvina   (Czech Republic)

Author keywords

Anti 2 glycoprotein I antibodies; Anticardiolipin antibodies; Antiphospholipid syndrome; Chemiluminescence immunoassay

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; BETA2 GLYCOPROTEIN 1; IMMUNOGLOBULIN CLASS;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOMATION; BLOOD COLLECTION TUBE; CHEMILUMINESCENCE IMMUNOASSAY; CHEMILUMINESCENCE IMMUNOASSAY KIT; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; SENSITIVITY AND SPECIFICITY; ANTAGONISTS AND INHIBITORS; COMPARATIVE STUDY; IMMUNOLOGY; LUMINESCENCE; REPRODUCIBILITY; VALIDATION STUDY;

ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN ISOTYPES; LUMINESCENCE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84981294324     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2015.151129     Document Type: Article

References (14)

1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for Definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4(2):295-306.
2. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999Jul;42(7):1309-11 Consensus Development Conference Research Support, Non-U.S. Gov't Review.
3. Devreese K, Hoylaerts ME. Laboratory diagnosis of the antiphospholipid Syndrome: a plethora of obstacles to overcome. Eur J Haematol 2009;83(1):1-16.
4. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic Therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):401S-28S.
5. Tincani A, Filippini M, Scarsi M, Galli M, Meroni PL. European attempts for the Standardization of the antiphospholipid antibodies. Lupus 2009;18(10):913-9.
6. Kuwana M, Matsuura E, Kobayashi K, Okazaki Y, Kaburaki J, Ikeda Y, Kawakami Y. Binding of β2 glycoprotein I to anionic phospholipids facilitates processing and presentation of a cryptic epitope that activates pathogenic autoreactive T-cells. Blood. 2005;105:1552-7.
7. Ichicawa K, Khamashta MA, Koike T, Matsuura E, Hughes GR. β2 Glycoprotein-I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome. Arthritis Rheum. 1994;37(10):1453-61.
8. Zucker S, Cathey MH, West B. Preparation of Quality Control Specimens for Coagulation. Am J Clin Pathol. 1970;53:924-7.
9. Decavele AS, Schouwers S, Devreese KM. Evaluation of three commercial ELISA kits for anticardiolipin and anti-beta2-glycoprotein protein I antibodies in the laboratory Diagnosis of the antiphospholipid syndrome. Int J Lab Hematol 2011;33(1):97-108.
10. J.L. Fleiss Statistical methods for rates and proportions (Second Ed.) John Wiley, New York (1981).
11. Tincani A, Filippini M, Scarsi M, Galli M, Meroni PL. European attempts for the standardisation of the antiphospholipid antibodies. Lupus 2009;18(10):913-9.
12. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995;74(4):1185-90.
13. Wong RC; Australasian aCL Working Party. Consensus guidelines for anticardiolipin antibody testing. Thromb Res 2004;114(5-6):559-71.
14. Pengo V. A contribution to the debate on the laboratory criteria that define the antiphospholipid syndrome. J Thromb Haemost 2008;6(6):1048-9.